Neos Therapeutics (NEOS) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free NEOS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCara Therapeutics, Inc. (CARA)finance.yahoo.com - April 21 at 10:03 AMAvenue Bank wins full APRA licence, bank guarantees in sightafr.com - March 3 at 7:20 PMPresidio Partners 2007 GP, L.P.'s Net Worthbenzinga.com - February 9 at 6:00 PMUSAntibiotics Expands Leadership Team with Appointment of Steven Lutz to Vice President of Strategic Accountsfinance.yahoo.com - December 14 at 12:59 PMEledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directorsfinanznachrichten.de - September 11 at 7:19 AMAytu BioPharma, Inc.: Aytu BioPharma Announces Submission of Cotempla XR-ODT Manufacturing Site Transfer Prior Approval Supplementfinanznachrichten.de - July 10 at 12:32 PMAytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplementfinance.yahoo.com - July 10 at 12:32 PMADHD Therapeutics Market Size Worth USD 19740 Million by 2030 at 7.80% CAGR – Report by Market Research Future (MRFR)finance.yahoo.com - May 29 at 12:22 PMOverview of Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Dynamics and Trends for 2023-2030marketwatch.com - May 12 at 12:23 AMGlobal ADHD Medication Market Analysis and Business Growth Outlook [2023-2030]marketwatch.com - April 28 at 8:27 PMAttention Deficit Hyperactivity Disorder (ADHD) Market by Product Type and Consumers-2030marketwatch.com - April 11 at 1:14 PMAttention Deficit Hyperactivity Disorder (ADHD) Market 2023 Size and Forecast to 2031marketwatch.com - April 4 at 3:57 PMAttention Deficit Hyperactivity Disorder Market to Register a Steady CAGR of 4.40% Between 2023 – 2031 | Growth Plus Reportsbenzinga.com - April 3 at 8:23 AMADHD Medication Market 2023 Size and Growth Forecast to 2028marketwatch.com - March 30 at 6:56 AM2023 Attention Deficit Hyperactivity Disorder (ADHD) Market: Top Players Best Practices and Sales Forecast 2030marketwatch.com - March 27 at 8:39 AMADHD Medication Market Outlook and Forecast till 2030marketwatch.com - March 24 at 1:02 PMAttention Deficit Hyperactivity Disorder (ADHD) Market Insights and Forecast to 2028marketwatch.com - March 21 at 6:52 AMThis report on ADHD Medication market presents a timeline of technical development and discusses how it affects the market.marketwatch.com - March 16 at 3:43 PMADHD Medication Market Analysis, Share by 2028marketwatch.com - March 14 at 9:36 AMGlobal Methylphenidate Drug Market Research Covers, Future Trends and Opportunities, Past, Present Data, and Deep Analysis 2030 By VMReportsmarketwatch.com - February 27 at 5:06 PMChildren Attention Deficit and Hyperactivity Disorder Market 2023: Strategies for Expanding into New Markets across Regions 2029marketwatch.com - February 19 at 2:55 PMAttention Deficit Hyperactivity Disorder (ADHD) Market Growth, Business Overview and Forecast to 2028marketwatch.com - February 15 at 12:18 AMAvenue Bank aims to free up cash for small businessafr.com - January 23 at 10:49 PMNykode Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 20 at 11:25 PMAttention Deficit Hyperactivity Disorder (ADHD) Market Size 2028 Size Estimation, New Investment Opportunities with Top Countries Datamarketwatch.com - January 11 at 8:01 AMAttention Deficit and Hyperactivity Disorder Market Analysis Research Report, Challenges, Scopes, Market Share, Revenue, and Forecasts 2022 to 2028marketwatch.com - October 12 at 11:25 AMAttention Deficit Hyperactivity Market by Size Estimation, Share Analysis with Recent Developments, Business prospects and Forecast 2022-2031marketwatch.com - October 2 at 9:08 PMAytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 Revenueca.finance.yahoo.com - September 27 at 6:33 PMAllarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directorsbenzinga.com - September 26 at 7:30 AMADHD Treatment Market 2022: Industry Growth, Technology Features and Analysis By 2028 with Leading Regions and Countries Datamarketwatch.com - August 19 at 3:38 PMCDB Aviation Executes Sale and Leaseback Transaction with New Middle Eastern Customer Jazeera Airwaysfinance.yahoo.com - July 16 at 3:45 AMAvidbots Neo Cleaning Robot Used by Many of the Newly Named Best Global Airportsnz.finance.yahoo.com - July 14 at 2:30 AMGlobal Attention Deficit Hyperactivity Disorder (ADHD) Market 2022: Share and Outlook of Regulatory Scenario by 2028marketwatch.com - June 3 at 12:03 AMAttention Deficit Hyperactivity Disorder Therapeutics Market 2022-2030 Global Industry Growth Opportunities, Analysis and Regional Forecastmarketwatch.com - May 25 at 6:01 PMInsights on the Dental Partnering Global Market - Trends in Dental Dealmaking in the Biopharma Industry Since 2010benzinga.com - May 24 at 11:23 PMStimulants Drugs Market Size 2022 by Research Methodology, Value Chain Analysis, Distributors and Forecast to 2029marketwatch.com - April 27 at 3:12 PMCobbs Creek Healthcare Hires Global Pharmaceutical Industry Leader Vince Mair as Presidentfinance.yahoo.com - January 20 at 10:29 AMWho's Hiring In The Columbia Area? See New Local Jobsmsn.com - January 18 at 8:32 PMAltimmune Appoints Richard Eisenstadt As Chief Financial Officer - Quick Factsnasdaq.com - December 13 at 6:47 AMAltimmune Names Richard Eisenstadt Finance Chiefmarketwatch.com - December 13 at 6:47 AMGlobal Trauma Fixation Device Pipeline Products Market Landscape Report 2021 - ResearchAndMarkets.comfinance.yahoo.com - December 9 at 11:23 PMAytu BioPharma, Inc.: Aytu BioPharma Reports First Quarter 2022 Financial Resultsfinanznachrichten.de - November 15 at 5:33 PMAytu BioPharma, Inc.: Aytu BioPharma Reports Fourth Quarter and Full-Year Fiscal 2021 Financial Resultsfinanznachrichten.de - September 27 at 7:23 PMImvax Appoints John M. Limongelli as Chief Legal Officerfinance.yahoo.com - September 17 at 7:56 PM Get Neos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOS and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him NEOS Media Mentions By Week NEOS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEOS News Sentiment▼0.000.46▲Average Medical News Sentiment NEOS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEOS Articles This Week▼10▲NEOS Articles Average Week Get Neos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KZR News Today GMTX News Today VAXX News Today RPHM News Today VHAQ News Today FIXX News Today CKPT News Today HCWB News Today IMRX News Today EGRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEOS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
